跳至主要内容
临床试验/NCT07068256
NCT07068256已完成不适用

Comparison Between Therapeutic Efficacy of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Pediatric Population.

Muhammad Aamir Latif1 个研究点 分布在 1 个国家目标入组 164 人开始时间: 2025年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
164
试验地点
1
主要终点
Fungus eradication

研究概览

简要总结

Several studies globally have assessed the efficacy of terbinafine and itraconazole in the treatment of tinea capitis, but local data in this regard is scarce. Therefore, this study was planned with the aim of assessing the difference between the therapeutic efficacy of itraconazole pulse therapy and terbinafine in children with tinea capitis.

详细描述

The existing literature carries varying results between the effectiveness of itraconazole pulse therapy and continuous terbinafine therapy in treating tinea capitis, and local data in this regard is also scarce. The findings of this study would not only add to the statistics but would also help clinicians to offer a treatment modality in pediatric tinea capitis, which should have better efficacy, a low incidence of side effects, and better patient compliance.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Year 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Any gender
  • Aged 1-13 years
  • With KOH mount positive before start of treatment
  • Duration of disease more than 1 month

排除标准

  • KOH mount negative before starting the treatment
  • Topical treatment with antifungal agents within past 4 weeks
  • Systemic treatment with antifungal agents within past 4 weeks
  • Patients with active liver disease
  • Patients with elevated liver enzymes

研究组 & 干预措施

Terbinafine group

Experimental

Patients will be given terbinafine in a dose of 62.5 mg for less than 20 kg body weight, 125 mg from 20 to 40 kg, and 250 mg for more than 40 kg for a period of 4 weeks.

干预措施: Terbinafine (Drug)

Itraconazole group

Experimental

Patients will receive itraconazole a dose of 5 mg/kg/day for 7 days and then 14 days off. Three such pulses will be given to the patients of this group.

干预措施: Itraconazole (Drug)

结局指标

主要结局

Fungus eradication

时间窗: 9 weeks

Treatment will be labeled efficacious if the patient will be cured clinically as well as mycologically, i.e., samples treated with KOH will show no fungal elements.

次要结局

未报告次要终点

研究者

发起方
Muhammad Aamir Latif
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Muhammad Aamir Latif

Research Consultant

RESnTEC, Institute of Research

研究点 (1)

Loading locations...

相似试验